Skip to main content
. 2022 Nov 5;23(21):13564. doi: 10.3390/ijms232113564

Figure 3.

Figure 3

Possible beneficial targets in ACE2-mediated SARS-CoV-2 infection. SARS-CoV-2 binds the cell receptor ACE-2 to facilitate entry after the spike protein is primed by membrane protease. The virus then replicates abundantly, producing replicates that efflux from host cells, resulting in damage and spreading. Potential therapeutic approaches include the use of a soluble form of ACE2 that competitively binds viruses.